Acquired factor VIII inhibitor in a non-haemophilic boy

Haemophilia

Volumn 9, Issue 5, 2003, Pages 642-645

  Klukowska, Anna ^a   Laguna P ^a   Obitko Pludowska A ^a   Niedzielska, K ^b   Malinowska, I ^a   Rokicka Milewska, R ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b University Hospital   (Poland)

Author keywords

Acquired haemophilia; Giant crus haematoma; Immunosuppressive treatment; PCC and activated PCC

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; AZATHIOPRINE; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISONE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VINCRISTINE;

ARTICLE; BLEEDING; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG EFFICACY; HEMATOMA; HEMOPHILIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; REMISSION; SKIN BRUISING; SKIN NECROSIS;

EID: 0141990536     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2003.00797.x     Document Type: Article

References (23)

1. Hay CRM. Acquired haemophilia. Bailliere Clin Haematol 1998; 11: 287-303.
2. Cohen AJ, Kessler CM. Acquired inhibitors. Bailliere Clin Haematol 1996; 9: 321-53.
3. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thrombos Haemostas 1981; 45: 200-3.
4. Mateo J, Martino R, Borrell M, Gari M, Casa F, Fontcuberta J. Acquired factor VIII inhibitor preceding chronic lymphoblastic leukemia. Am Hematol 1993; 67: 309-11.
5. Stewart AJ, Manson LM, Dasani H et al. Acquired haemophilia in recipients of depot thioxanthenes. Haemophilia 2000; 6: 709-12.
6. Lionner F, Pulik M, Gener P, Lucas G, Sollet J-P. Acquired factor VIII inhibitor associated with a prostatic cancer: simultaneous occurence and healing. Thrombos Haemostas 1995; 73: 327-8.
7. Hultin MB. Acquired inhibitors in malignant and nonmalignant states. Am J Med 1991; 91(Suppl. 5A): 9-13.
8. Schwerdtfeger R, Hintz G, Huhn D. Successful treatment of a patient with postpartum factor VIII inhibitor with recombinant human interferon α 2a. Am J Hematol 1991; 37: 190-3.
9. Hauser I, Schneider B, Lechner K. Post-partum factor VIII inhibitors. Thrombos Haemostas 1995; 73: 1-5.
10. Mazzucconi MG, Bizzoni L, Giorgi A et al. Postpartum inhibitor to factor VIII: treatment with high-dose immunoglobulin and dexamethasone. Haemophilia 2001; 7: 422-7.
11. Ryan BR, Arkel Y, Walters TR, Frimmer D, Desposito F. Acquired symptomatic inhibitors of plasma clotting factors in nonhemophilic children. Am J Pediatr Hematol/Oncol 1986; 8: 144-8.
12. Desposito F, Arkel YS. Acquired anticoagulants (inhibitors) in hemophilic and nonhemophilic children. Intern J Ped Hematol/Oncol 1994; 1: 93-109.
13. Proctor RR, Rapaport SJ. The partial thromboplastin time with kaolin. Am J Clin Pathol 1961; 36: 212-6.
14. Łopaciuk S. Blood coagulation tests. In: Pawelski S, ed. Laboratory Diagnostics in Haematology (Pol). ed. Pawelski S, Warsaw: PZWL, 1983: 247-9.
15. Kasper CK, Aledort LA, Counts RB et al. A more uniform measurement of factor VIII inhibitors. Thrombosis et Diathesis Haemorrhagica 1975; 34: 869-72.
16. Kernoff PBA. Rationale and evolution of therapy with porcine factor VIII:C. Am J Med 1991; 91(Suppl. 5A): 20-6.
17. Klukowska A, Łaguna P, Obitko-Płudowska A, Rokicka-Milewska R. Use of activated recombinant factor VII (rFVIIa) in treatment of haemophilic children with high inhibitor level (Pol). Acta Haematol Pol 1998; 29: 401-6.
18. Green D. Cytotoxic suppresion of acquired factor VIII:C inhbitors. Am J Med 1991; 91 (Suppl. 5A): 14-9.
19. Green D, Rademaker AW, Briet E. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thrombos Haemostas 1993; 70: 753-7.
20. Lian EC-Y, Larcada AF, Chiu AY-Z. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann Intern Med 1989; 110: 774-8.
21. Sultan Y, Maisonneuve P, Kazatchkine MD, Nydegger UE. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet 1984; 765-8.
22. Sultan Y, Kaztchkine MD, Nydegger U, Rossi F, Dietrich G, Algiman M. Intravenous immunoglobulin in the treatment of spontaneously acquired factor VII:C inhibitors. Am J Med 1991; 91(Suppl. 5A): 35-9.
23. Schwartz RS, Gabriel DA, Aledort LM, Green D, Kessler CM. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood 1996; 86: 797-804.